Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer

Anti-Cancer Drugs

Volumn 22, Issue 4, 2011, Pages 371-376

  Huerta, Sergio ^a   Gao, Xiaohuan ^a   Saha, Debabrata ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

HT 29 colorectal cancer cells; in vivo imaging system; ionizing radiation; pathological complete response; radiation enteritis; radioresistance

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BIOLUMINESCENCE; CANCER MODEL; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; COLORECTAL CANCER; DISEASE COURSE; GENETIC TRANSFECTION; IONIZING RADIATION; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RADIOGRAPHY; SENSITIVITY ANALYSIS; TUMOR LOCALIZATION;

ANIMALS; CELL LINE, TUMOR; HCT116 CELLS; HT29 CELLS; HUMANS; LUCIFERASES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION TOLERANCE; RECTAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952988260     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32834367c7     Document Type: Article

References (14)

1. Huerta S, Hrom J, Gao X, Saha D, Anthony T, Reinhart H, et al. Tissue microarray constructs to predict a response to chemoradiation in rectal cancer. Dig Liver Dis 2010;42:679-684.
2. Tseng W, Leong X, Engleman E. Orthotopic Mouse Model of Colorectal Cancer. JoVE.10. http://www.jove.com/index/Details.stp?ID=484 2007.
3. Gao X, Saha D, Kapur P, Anthony T, Livingston EH, Huerta S. Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate. J Surg Oncol 2009;100:149-158.
4. Huerta S, Gao X, Livingston EH, Kapur P, Sun H, Anthony T. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201. Surgery 2010;148:346-353.
5. Paroo Z, Bollinger RA, Braasch DA, Richer E, Corey DR, Antich PP, et al. Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 2004;3:117-124.
6. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000;2:491-495. (Pubitemid 32098683)
7. Bilger A, Shoemaker AR, Gould KA, Dove WF. Manipulation of the mouse germline in the study of Min-induced neoplasia. Semin Cancer Biol 1996;7:249-260. (Pubitemid 27182784)
8. Huerta S, Irwin RW, Heber D, Go VL, Koeffler HP, Uskokovic MR, et al. 1alpha, 25-(OH) (2)-D (3) and its synthetic analogue decrease tumor load in the Apc (min) mouse. Cancer Res 2002;62:741-746. (Pubitemid 34126949)
9. Huerta S, Irwin RW, Heber D, Go VL, Moatamed F, Ou C, et al. Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis. Dig Dis Sci 2003;48:870-876. (Pubitemid 36470204)
10. Huerta S, Arteaga JR, Irwin RW, Ikezoe T, Heber D, Koeffler HP, et al. PC-SPES inhibits colon cancer growth in vitro and in vivo. Cancer Res 2002;62:5204-5209. (Pubitemid 35024591)
11. Chen J, Huang XF. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol Ther 2009;8:1313-1317.
12. Kashtan H, Rabau M, Mullen JB, Wong AH, Roder JC, Shpitz B, et al. Intrarectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol 1992;1:251-256.
13. Donigan M, Norcross LS, Aversa J, Colon J, Smith J, Madero-Visbal R, et al. Novel murine model for colon cancer: non-operative trans-anal rectal injection. J Surg Res 2009;154:299-303.
14. Sweeney TJ, Mailander V, Tucker AA, Olomu AB, Zhang W, Cao Y, et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 1999;96:12044-12049. (Pubitemid 29502855)